8.34 USD
↘ 1.59 (16.01%)AT CLOSE (11:59 AM EDT)
Atara Biotherapeutics, Inc
ATRANASDAQ • USD
9.35
↗ 1.01 (12.11%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
9.35
↗ 1.01 (12.11%)
Market: CLOSED
Open?$9.65
High?$9.93
Low?$7.85
Prev. Close?$9.93
Volume?3.0M
Avg. Volume?2.6M
VWAP?$8.76
Rel. Volume?1.14x
Bid / Ask
Bid?$9.08 × 100
Ask?$9.40 × 800
Spread?$0.32
Midpoint?$9.24
Valuation & Ratios
Market Cap?84.5M
Shares Out?8.5M
Float?2.6M
Float %?36.0%
P/E Ratio?2.59
P/B Ratio?-2.20
EPS?$3.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Themes
Employees
14
Market Cap
71.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2014-10-16
Address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS, CA 91320
Phone: 805-623-4211
THOUSAND OAKS, CA 91320
Phone: 805-623-4211
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.82Weak
Quick Ratio?0.82Weak
Cash Ratio?0.57Adequate
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?2.6CHEAP▾
P/B?-2.20CHEAP▾
P/S?0.70CHEAP▾
P/FCF?N/A▾
EV/EBITDA?2.0CHEAP▾
EV/Sales?0.63CHEAP▾
Returns & Efficiency
ROE?-84.9%WEAK▾
ROA?161.5%STRONG▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$76.0M
Fundamentals ratios updated end of day